Osteoarthritis Global Clinical Trials Review, H1, 2016
ReportsWeb.com published “Osteoarthritis Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, January 26, 2018 ) Publisher's clinical trial report, "Osteoarthritis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Publisher Clinical Trial Reports are generated using Publisher's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
For more information about this report at http://www.reportsweb.com/osteoarthritis-global-clinical-trials-review-h1-2016
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001178647/sample
Companies Mentioned
Pfizer Inc.
Novartis AG
Johnson & Johnson
C. H. Boehringer Sohn AG & Co. KG
Merck & Co., Inc.
Sanofi
Mundipharma International Ltd
Fidia farmaceutici S.p.A.
AstraZeneca Plc
AbbVie Inc.
Table of Contents
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Top Five Countries Contributing to Clinical Trials in Central and South America 13
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Osteoarthritis Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Osteoarthritis 29
Jan 28, 2016: Medivir initiates phase IIa study of MIV-711 in knee osteoarthritis 29
Jan 13, 2016: Cellular Biomedicine Group Announces Positive 48-Week Data from Phase IIb Clinical Trial for Knee Osteoarthritis Stem Cell ReJoin Therapy 29
Jan 06, 2016: Zynerba Pharmaceuticals Announces Positive Initial Results From ZYN002 CBD Gel Phase 1 Single Rising Dose Trial and Initiation of Phase 1 Multiple Rising Dose Trial 30
Jan 06, 2016: Launch of Phase I clinical Trial for AlloJoin Off-the-Shelf Allogeneic Stem Cell Therapy for KOA 31
Dec 22, 2015: Upcoming Presentation to Release 48-Week Data From Phase IIb Clinical Trial for ReJoin 31
Dec 21, 2015: Antibe Therapeutics Announces Completion of Validation Studies of ATB-346, Progression to Phase 2 Clinical Trials 31
Dec 09, 2015: Cara Therapeutics Announces Positive Top-Line Results From Phase 2a Trial of Oral CR845 in Chronic Pain Patients With Osteoarthritis of the Knee or Hip 32
Dec 01, 2015: Flexion Therapeutics Enrolls First Patient in Pharmacokinetic Study of Zilretta for Osteoarthritis of the Knee 33
Clinical Trial Profile Snapshots 34
Appendix 741
Abbreviations 741
Definitions 741
Research Methodology 742
Secondary Research 742
About GlobalData 743
Contact Us 743
Disclaimer 743
Source 744
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001178647/buying
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
For more information about this report at http://www.reportsweb.com/osteoarthritis-global-clinical-trials-review-h1-2016
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001178647/sample
Companies Mentioned
Pfizer Inc.
Novartis AG
Johnson & Johnson
C. H. Boehringer Sohn AG & Co. KG
Merck & Co., Inc.
Sanofi
Mundipharma International Ltd
Fidia farmaceutici S.p.A.
AstraZeneca Plc
AbbVie Inc.
Table of Contents
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Top Five Countries Contributing to Clinical Trials in Central and South America 13
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Osteoarthritis Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Osteoarthritis 29
Jan 28, 2016: Medivir initiates phase IIa study of MIV-711 in knee osteoarthritis 29
Jan 13, 2016: Cellular Biomedicine Group Announces Positive 48-Week Data from Phase IIb Clinical Trial for Knee Osteoarthritis Stem Cell ReJoin Therapy 29
Jan 06, 2016: Zynerba Pharmaceuticals Announces Positive Initial Results From ZYN002 CBD Gel Phase 1 Single Rising Dose Trial and Initiation of Phase 1 Multiple Rising Dose Trial 30
Jan 06, 2016: Launch of Phase I clinical Trial for AlloJoin Off-the-Shelf Allogeneic Stem Cell Therapy for KOA 31
Dec 22, 2015: Upcoming Presentation to Release 48-Week Data From Phase IIb Clinical Trial for ReJoin 31
Dec 21, 2015: Antibe Therapeutics Announces Completion of Validation Studies of ATB-346, Progression to Phase 2 Clinical Trials 31
Dec 09, 2015: Cara Therapeutics Announces Positive Top-Line Results From Phase 2a Trial of Oral CR845 in Chronic Pain Patients With Osteoarthritis of the Knee or Hip 32
Dec 01, 2015: Flexion Therapeutics Enrolls First Patient in Pharmacokinetic Study of Zilretta for Osteoarthritis of the Knee 33
Clinical Trial Profile Snapshots 34
Appendix 741
Abbreviations 741
Definitions 741
Research Methodology 742
Secondary Research 742
About GlobalData 743
Contact Us 743
Disclaimer 743
Source 744
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001178647/buying
Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results